VERALOX THERAPEUTICS Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for VERALOX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERALOX THERAPEUTICS trademark a serial number of 88976190. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by Veralox Therapeutics Inc.. The VERALOX THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical and biotechnology preparations and medicines; pharmaceutical research and development; biotechnology research and development; biopharmaceutical research and development
veralox therapeutics

General Information

Serial Number88976190
Word MarkVERALOX THERAPEUTICS
Filing DateFriday, November 16, 2018
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5932187
Registration DateTuesday, December 10, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesDevelopment of pharmaceutical and biotechnology preparations and medicines; pharmaceutical research and development; biotechnology research and development; biopharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code042
First Use Anywhere DateThursday, September 7, 2017
First Use In Commerce DateWednesday, September 13, 2017

Trademark Owner History

Party NameVeralox Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703
Party NameVeralox Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704
Party NameVeralox Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704

Trademark Events

Event DateEvent Description
Monday, February 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 5, 2019NOTICE OF ALLOWANCE CANCELLED
Tuesday, November 5, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, October 23, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, November 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 23, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 14, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 14, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 25, 2019ASSIGNED TO LIE
Tuesday, March 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, March 5, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, February 27, 2019NON-FINAL ACTION WRITTEN
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics veralox development research biotechnology pharmaceutical biopharmaceutical preparations medicines